Comment by
ibsn4512 on Jul 20, 2021 4:35am
Reason number 1 is they loose a lot of money!
Comment by
PercySweetwater on Jul 20, 2021 7:25am
TSX regulators would not allow DM to administer tests, which is why Screen Pro was set up in the first place. TSX regulators would not allow DM to purchase Screen Pro.
Comment by
MomenTom on Jul 20, 2021 7:37am
I don't think the last part is true. During last discord Marshall got asked if they would buy ScreenPro and he answered that he cannot discuss that kind of information but that if they acquire it, we will know in a news release along with everyone else. I would dare say DM cannot perform testing, but they can own a subsidiary who does. (I may very well be wrong, just saying)
Comment by
MomenTom on Jul 20, 2021 8:18am
@Resilience. Thanks for your post, I'm with you on this. I wouldn't buy SCRN either, more focus on making AI work.
Comment by
MUTDMUTD on Jul 20, 2021 8:44am
... nice Resilience!... Will you send that to Marshall directly? If not I will.... DBO is 3rd for me after DM and SCRN... both in potential and position... DBO has some crazy potential... they just need to execute their plan now.... All IMO. DYODD.
Comment by
Resilience19 on Jul 20, 2021 8:53am
MUTD, I've already alluded to MG that DBO may be a good (affordable) fit, through email, a few weeks ago. To hear it from another source may help further catch his eye/interest. So you're welcome to drop him a line accordingly :-) Note that I currently don't hold a position in DBO but have it on my watch list.
Comment by
MUTDMUTD on Jul 20, 2021 8:57am
... I'll follow up with MG... thanks. I got into DBO a long time ago at $0.04, watched it go to $0.27, should have sold but didn't, the sold at $0.11. Bought back in at $0.105 recently for a very small portion of shares and at $0.03 for warrants, which seem to be the best deal IMO, at a larger portion...
Comment by
frewil11 on Jul 20, 2021 10:17am
This cannot be a serious post.